Clinical trials located in

Vitoria Gasteiz

Vitoria Gasteiz city is located in Spain. Currently, 1 clinical trials are being conducted in this city.

  • CT-EU-00110832

    Testing a new drug (SAR442501) for safety and effectiveness in children with achondroplasia

    This is a Phase 2 clinical trial investigating the safety, tolerability, and efficacy of an investigational drug called SAR442501 in children from birth up to 12 years of age with Achondroplasia, a type of skeletal dysplasia. The study will involve administering SAR442501 as a subcutaneous injection (under the skin) to participants. The primary objective is to evaluate the number of participants who experience adverse events, serious adverse events, and adverse events of special interest during the first 52 weeks of treatment.

    The study will have a screening period of 3 weeks, followed by a 52-week primary treatment period, and then an extended treatment period of up to approximately 216 weeks (over 4 years). After completing the treatment periods, participants will undergo a 4-week follow-up period. The total duration of the study could be up to approximately 275 weeks (over 5 years).

    This clinical trial aims to gather important information about the safety profile, tolerability, and potential efficacy of SAR442501 in treating Achondroplasia, a rare skeletal disorder, in children. Participants will be closely monitored throughout the study to ensure their well-being and to collect valuable data that could contribute to the development of a potential new treatment option for this condition.

    • SAR442501

See more clinical trials in other cities in Spain: